Press ENTER to search

Bupa receives formal approval of its science-based targets

  • Bupa, the international healthcare company, announces that the Science Based Targets initiative has formally approved its science-based targets for all emission scopes.
  • Bupa’s targets are aligned to keep global warming to no more than 1.5°C compared to pre-industrial levels; the most ambitious reduction pathway.
  • People’s health and the health of the planet are intrinsically linked, which is why sustainability is core to Bupa’s strategy and refreshed purpose.

Bupa has received validation of its ambitious Scope 1, 2 and 3 science-based emissions targets with approval from the Science Based Targets initiative (SBTi).

The SBTi commended Bupa’s 1.5°C-aligned targets; currently the most ambitious designation available through the process and in-line with the levels required to meet the Paris agreement goals.

These targets underpin Bupa’s ambition to become a net zero business by 2040 across its global healthcare operations and value chain, including its investment portfolio, and they will help ensure that Bupa makes transformational progress this decade.

Bupa’s Chief Sustainability and People Officer, Nigel Sullivan, said: “Having our targets approved by the Science Based Targets initiative underlines our commitment to significantly reduce our greenhouse gas emissions in line with recommendations from climate scientists.

We understand the role that we must play, working with others, to drive urgent action to ensure a healthy planet for healthy people. Achieving these targets will require systemic change and radical collaboration between all stakeholders; businesses, governments, consumers, suppliers and the third sector. It’s not going to be easy, but decisive action is critical.”

Enquiries

Duncan West, Head of Corporate Communications, Bupa Group: [email protected]

Notes to editor

Bupa’s Scope 1, 2 and 3 targets approved by the SBTi are as follows:

  • Reduce our absolute Scope 1 and 2 GHG emissions by at least 46.2% by 2030 from a 2019 base year.
  • Reduce our absolute Scope 3 GHG emissions from purchased goods and services, including insurance-related services, business travel, downstream transportation and distribution by at least 63% by 2034 from a 2019 base year.
  • Align our investment portfolio with 1.5 degrees by 2040 and achieve 25% of the required reduction based on temperature alignment by 2025 from 2020 base year.

As well as regular reporting on progress against these targets, as part of the Race to Zero campaign, Bupa will provide annual quantitative and qualitative reports on progress and strategies to Health Care Without Harm and the United Nations Framework Convention on Climate Change.

About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.

We are an international healthcare company serving over 38 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.

We directly employ around 84,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.